Literature DB >> 12887698

The structure of neuromelanin as studied by chemical degradative methods.

Kazumasa Wakamatsu1, Kenichi Fujikawa, Fabio A Zucca, Luigi Zecca, Shosuke Ito.   

Abstract

The biosynthesis, structure and function of neuromelanin (NM), the dark brown melanin-like pigment present in the substantia nigra (SN), are not well characterized, in spite of the possible involvement of NM in the etiology and pathogenesis of Parkinson's disease. NM was isolated from the SN of five non-Parkinsonian human brains. NM and synthetic melanins, employed as models, were characterized by chemical analysis. Alkaline hydrogen peroxide (H2O2) oxidation of NM generated four degradation products, pyrrole-2,3-dicarboxylic acid (PDCA), pyrrole-2,3,5-tricarboxylic acid (PTCA), thiazole-4,5-dicarboxylic acid (TDCA) and thiazole-2,3,5-tricarboxylic acid (TTCA), whose ratios, especially the TTCA to PDCA ratio, indicate that NM is derived mostly from dopamine (DA) with 25% incorporation of cysteine (Cys) in the form of a benzothiazine structure. Hydriodic acid (HI) reductive hydrolysis of NM yielded 4-amino-3-hydroxyphenylethylamine (4-AHPEA) as a marker of cysteinyldopamine (CysDA)-derived units. The 4-AHPEA to PDCA ratio indicates a 21% incorporation of CysDA-derived units into NM. These degradative experiments also suggest that DOPA is not incorporated into NM to a significant extent (approximately 6% the level of DA). It is concluded that the TTCA to PDCA ratio is a useful indicator of CysDA-derived units in NM, and NM consists mainly of DA-melanin with some contribution from CysDA-melanin. The involvement of DA and CysDA as building blocks of NM demonstrates the detoxifying role of NM synthesis, since it prevents the intraneuronal accumulation of DA and CysDA, which would cause toxic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887698     DOI: 10.1046/j.1471-4159.2003.01917.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  45 in total

Review 1.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

2.  Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometry.

Authors:  A Dzierzega-Lecznar; S Kurkiewicz; K Stepien; E Chodurek; P Riederer; M Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2006-05-12       Impact factor: 3.575

3.  Encapsulation of a reactive core in neuromelanin.

Authors:  Shosuke Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

4.  The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.

Authors:  William D Bush; Jacob Garguilo; Fabio A Zucca; Alberto Albertini; Luigi Zecca; Glenn S Edwards; Robert J Nemanich; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

Review 5.  Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration.

Authors:  Romana Fato; Christian Bergamini; Serena Leoni; Paola Strocchi; Giorgio Lenaz
Journal:  Neurochem Res       Date:  2008-06-06       Impact factor: 3.996

Review 6.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

7.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

8.  The expanding role and presence of neuromelanins in the human brain - why gray matter is gray.

Authors:  Vincent J Hearing
Journal:  Pigment Cell Melanoma Res       Date:  2008-12-19       Impact factor: 4.693

9.  New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.

Authors:  Luigi Zecca; Chiara Bellei; Patrizia Costi; Alberto Albertini; Enrico Monzani; Luigi Casella; Mario Gallorini; Luigi Bergamaschi; Alberto Moscatelli; Nicholas J Turro; Melvin Eisner; Pier Raimondo Crippa; Shosuke Ito; Kazumasa Wakamatsu; William D Bush; Weslyn C Ward; John D Simon; Fabio A Zucca
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

10.  Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase.

Authors:  Arthur J L Cooper; John T Pinto; Boris F Krasnikov; Zoya V Niatsetskaya; Qian Han; Jianyong Li; David Vauzour; Jeremy P E Spencer
Journal:  Arch Biochem Biophys       Date:  2008-02-29       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.